UNODC World Drug Report 2024
A global reference on drug markets, trends and policy developments, the World Drug Report offers a wealth of data and analysis and in 2024 comprises several elements tailored to different audiences.
Search
European Drug Report 2024: Trends and Developments
The European Drug Report 2024: Trends and Developments presents the EMCDDA’s latest analysis of the drug situation in Europe. Focusing on illicit drug use, related harms and drug supply, the report provides a comprehensive set of...
The Challenge of New Psychoactive Substances – A Technical Update 2024
"The Challenge of New Psychoactive Substances – A Technical Update 2024" is an update of the UNODC publication “The Challenge of New Psychoactive Substances (NPS), 2013”, which focuses on the new psychoactive substances (NPS) encountered on...
The Declaration of Oviedo: Incorporating Prevention in Drug Policies
Presented at Thessaloniki 2024 - Panel: Investing in Public Health, on the 28th of June, 2024.
Research Update from the National Institute on Drug Abuse
Presented at Thessaloniki 2024 - Panel: Investing in Public Health, on the 28th of June, 2024.
Empowering Change: Strategies for Navigating Your Policy Advocacy Journey
Presented at Thessaloniki 2024 - Panel: Investing in Public Health, on the 28th of June, 2024.
Example of fully functioning digital national infrastructural support IPREV for school and community prevention activities: a compact simple system means understandable, acceptable and sustainable solution
Presented at Thessaloniki 2024 - Panel: Investing in Public Health, on the 28th of June, 2024.
Public Health of Addiction
Presentes at Thessaloniki 2024 - Panel: Investing in Public Health, on the 28th of June, 2024.
Spanish Project of Best Practice Portal in Drug Demand Reduction and Behavioural Addictions
INTRODUCTION:
In Spain, the offer of prevention programmes is very varied and structured, but today the challenge remains how to put evidence into practice. European Commission define a best practice as “a relevant policy or intervention...
Implementing Quality Measurement in the Field of Drug Treatment and Harm Reduction: A Case Study in Flanders
BACKGROUND:
Implementing quality measurement is still a challenge in the field of drug treatment and harm reduction. In this case study, we investigate which strategies can be used to enhance the implementation of a policy in which...
The Implementation of Quality Standards (QS) at Coolmine Therapeutic Community
BACKGROUND:
Coolmine’s implementation of quality standards involves a period of change management, strategic planning, and national policy development.
METHODS:
A narrative case study focusing on national policy and internal...
Canada’s Guidance on Alcohol and Health: Final Report
The report summarises the evidence drawn from worldwide evidence reviews, mathematical modelling, and extensive consultations and discussions. The Guidance provides people in Canada with accurate and current information about the risk of...
Alternatives to Incarceration: Alternatives to Incarceration A Smart Approach to Breaking the Cycle of Drug Use and Crime
The Office of National Drug Control Policy (ONDCP) highlights the strong link between drug use and criminal behavior, recognizing addiction as a disease requiring public health and safety interventions. The administration aims to break the cycle of drug use and crime through innovative, evidence-based approaches. These include smart probation strategies, like Hawaii's HOPE program and South Dakota's 24/7 Sobriety Project, which emphasize swift and certain sanctions for violations, reducing recidivism and saving costs. Drug courts, which combine treatment with judicial oversight, have shown success in reducing substance use and criminal activity. The administration supports expanding these programs to improve public safety and health outcomes while reducing correctional costs.
Aspectos Toxicológicos del Cigarrillo Electrónico
ISSUP Colombia presenta su webinar sobre “Aspectos Toxicológicos de los Cigarrillos Electrónicos”.
Trauma exposure across the lifespan among individuals engaged in treatment with medication for opioid use disorder: differences by gender, PTSD status, and chronic pain
There is little study of lifetime trauma exposure among individuals engaged in medication treatment for opioid use disorder (MOUD). A multisite study provided the opportunity to examine the prevalence of lifetime trauma and differences by gender, PTSD status, and chronic pain.
Neonatal Abstinence Syndrome and its Specifics at Temporary Foster Care Institution in the Czech Republic: Study Protocol
INTRODUCTION: Neonatal Abstinence Syndrome (NAS) is a condition unique to a newborn that results from the abrupt cessation of chronic intrauterine drug exposure following birth. Slightly persistent, late onsetting, or slowly fading-out...
AddictologyIssue 4/2023
Substance Use Disorder in Afghanistan: The Situation and Needs to Address the Issue
INTRODUCTION: More than four decades of war and tragedy have destroyed most of the public infrastructure in Afghanistan. Currently, drug use is a major public health crisis in the country and drug treatment services have extremely limited...
AddictologyIssue 4/2023
Spanish University Postgraduate Training on Addictions: The Historic Development and its Current Situation
BACKGROUND: Drug dependence is a public health problem that requires trained professionals to effectively address this issue. The aim of this study was to analyse postgraduate university training programs specialising in addictions in Spain...
AddictologyIssue 4/2023
Cognitive Deficits of People with Alcohol Dependence
INTRODUCTION: Excessive alcohol consumption is associated with a wide range of cognitive deficits observed in varying degrees among users. The aim of the research was to compare performance across different domains of cognition in a...
AddictologyIssue 4/2023
Call for Speakers: INCB Civil Society Hearing 2024
We are looking for civil society experts wishing to speak at this years INCB Civil Society Hearing
Topic: “scenarios and possible responses to the rapid expansion of synthetic drug manufacture, trafficking, marketing and consumption”
...